Re: Novel Immediate/Sustained-Release Formulation of Acetaminophen-Ibuprofen Combination (Paxerol (R)) for Severe Nocturia Associated with Overactive Bladder: A Multi-Center, Randomized, Double Blinded, Placebo-Controlled, 4-Arm Trial

Wein Alan J.

首页> 外文期刊>The Journal of Urology >Re: Novel Immediate/Sustained-Release Formulation of Acetaminophen-Ibuprofen Combination (Paxerol (R)) for Severe Nocturia Associated with Overactive Bladder: A Multi-Center, Randomized, Double Blinded, Placebo-Controlled, 4-Arm Trial

【24h】

Re: Novel Immediate/Sustained-Release Formulation of Acetaminophen-Ibuprofen Combination (Paxerol (R)) for Severe Nocturia Associated with Overactive Bladder: A Multi-Center, Randomized, Double Blinded, Placebo-Controlled, 4-Arm Trial

机译：Re：新型立即/缓释制剂对乙酰氨基酚-sbuprofen组合（Paxerol），用于与过度活性膀胱相关的严重夜尿：多中心，随机，双盲，安慰剂控制，4-ARM试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2019年第2期|共2页
作者
Wein Alan J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Novel Immediate/Sustained-Release Formulation of Acetaminophen-Ibuprofen Combination (Paxerol (R)) for Severe Nocturia Associated with Overactive Bladder: A Multi-Center, Randomized, Double Blinded, Placebo-Controlled, 4-Arm Trial [J] . Wein Alan J. The Journal of Urology . 2019,第2期

机译：Re：新型立即/缓释制剂对乙酰氨基酚-sbuprofen组合（Paxerol），用于与过度活性膀胱相关的严重夜尿：多中心，随机，双盲，安慰剂控制，4-ARM试验
2. NOVEL PROLONGED ACTION FORMULATION OF ACETAMINOPHEN-IBUPROFEN COMBINATION (PAXEROL (R)) THERAPY FOR TREATMENT OF NOCTURIA: A MULTI-CENTER, RANDOMIZED, DOUBLE BLINDED, PLACEBO-CONTROLLED, 4-ARM PHASE 2 TRIAL [J] . Kashan M., Khusid J. A., Weiss J. P., Neurourology and urodynamics. . 2018,第Suppla5期

机译：新型延长动作制剂对乙酰氨基酚 - 布洛芬组合（Paxerol）治疗治疗Nocturia：多中心，随机，双盲，安慰剂控制，4臂2试验
3. NOVEL PROLONGED ACTION FORMULATION OF ACETAMINOPHEN-IBUPROFEN COMBINATION (PAXEROL (R)) THERAPY FOR TREATMENT OF NOCTURIA: A MULTI-CENTER, RANDOMIZED, DOUBLE BLINDED, PLACEBO-CONTROLLED, 4-ARM PHASE 2 TRIAL [J] . Kashan M., Khusid J. A., Weiss J. P., Neurourology and urodynamics. . 2018,第Suppla5期

机译：新型延长动作制剂对乙酰氨基酚 - 布洛芬组合（Paxerol）治疗治疗Nocturia：多中心，随机，双盲，安慰剂控制，4臂2试验
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. Image-Analysis with Fiji Program on Peripheral Blood Monocular Cells After Consumption of High-Fat, High Carbohydrate Meal with or Without Addition of Spices: A Single-Center Randomized, Blinded, Placebo-Controlled, 4-Arm, 24-hr Acute Crossover Study [D] . Tsai, Meng Fu. 2020

机译：用斐济单眼细胞进行斐济血液单眼细胞的图像分析，用或没有添加香料：单中心随机，盲，安慰剂控制，4臂，24小时急性交叉研究
6. The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center randomized double-blind placebo-controlled study in Asian patients [O] . Yoshifumi Koshino, Won-Myong Bahk, Hideaki Sakai, 2013

机译：安非他酮缓释制剂治疗重大抑郁症的功效和安全性：亚洲患者的多中心随机双盲安慰剂对照研究
7. Novel immediate/sustained‐release formulation of acetaminophen‐ibuprofen combination (Paxerol®) for severe nocturia associated with overactive bladder: A multi‐center, randomized, double blinded, placebo‐controlled, 4‐arm trial [O] . King C. Lee, Frank Rauscher, Jed Kaminesky, 2018

机译：对乙酰氨基酚-Sbuprofen组合（Paxerol®）的新型立即/缓释制剂用于严重夜尿组合（Paxerol®），其与过度活性膀胱相关联：多中心，随机，双盲，安慰剂控制，4臂试验

Re: Novel Immediate/Sustained-Release Formulation of Acetaminophen-Ibuprofen Combination (Paxerol (R)) for Severe Nocturia Associated with Overactive Bladder: A Multi-Center, Randomized, Double Blinded, Placebo-Controlled, 4-Arm Trial

著录项

相似文献

相关主题

期刊订阅